-
Something wrong with this record ?
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients
V. Hrabovský, V. Takáčová, E. Schréterová, L. Pastvová, Z. Hrabovská, K. Čurová, L. Siegfried,
Language English Country United States
Document type Journal Article
- MeSH
- Amphotericin B pharmacology MeSH
- Antifungal Agents pharmacology MeSH
- Candida classification drug effects genetics isolation & purification MeSH
- Fluconazole pharmacology MeSH
- Drug Resistance, Fungal MeSH
- Intensive Care Units statistics & numerical data MeSH
- Candidiasis microbiology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Voriconazole pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Yeasts frequently colonize non-sterile sites in the body. The aim of the study was to determine distribution in clinical samples and antifungal susceptibility to five antifungals. From January 2013 through June 2015, 800 isolates were obtained from intensive care unit patients. Candida albicans (58.9%), Candida glabrata (20.4%), Candida krusei (8.6%), and Candida parapsilosis (3.6%) were the leading species. Majority of the C. albicans isolates were susceptible to the fluconazole. Elevated voriconazole minimal inhibitory concentrations (MICs) were observed in isolates exhibiting high fluconazole MICs, most frequently in C. glabrata. Isolates with echinocandins MICs suggesting reduced susceptibility were only sporadic cases with the exception of Trichosporon spp. The amphotericin B MICs were slightly higher for some C. krusei.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18020913
- 003
- CZ-PrNML
- 005
- 20180608120142.0
- 007
- ta
- 008
- 180608s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-017-0525-8 $2 doi
- 035 __
- $a (PubMed)28361459
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hrabovský, Vladimír $u Institute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia. vladimir.hrabovsky@upjs.sk.
- 245 10
- $a Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients / $c V. Hrabovský, V. Takáčová, E. Schréterová, L. Pastvová, Z. Hrabovská, K. Čurová, L. Siegfried,
- 520 9_
- $a Yeasts frequently colonize non-sterile sites in the body. The aim of the study was to determine distribution in clinical samples and antifungal susceptibility to five antifungals. From January 2013 through June 2015, 800 isolates were obtained from intensive care unit patients. Candida albicans (58.9%), Candida glabrata (20.4%), Candida krusei (8.6%), and Candida parapsilosis (3.6%) were the leading species. Majority of the C. albicans isolates were susceptible to the fluconazole. Elevated voriconazole minimal inhibitory concentrations (MICs) were observed in isolates exhibiting high fluconazole MICs, most frequently in C. glabrata. Isolates with echinocandins MICs suggesting reduced susceptibility were only sporadic cases with the exception of Trichosporon spp. The amphotericin B MICs were slightly higher for some C. krusei.
- 650 _2
- $a amfotericin B $x farmakologie $7 D000666
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a Candida $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D002175
- 650 _2
- $a kandidóza $x mikrobiologie $7 D002177
- 650 _2
- $a fungální léková rezistence $7 D025141
- 650 _2
- $a flukonazol $x farmakologie $7 D015725
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jednotky intenzivní péče $x statistika a číselné údaje $7 D007362
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a vorikonazol $x farmakologie $7 D065819
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Takáčová, Victoria $u Institute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
- 700 1_
- $a Schréterová, Eva $u Institute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
- 700 1_
- $a Pastvová, Lydia $u Institute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
- 700 1_
- $a Hrabovská, Zuzana $u Department of Dermatovenerology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
- 700 1_
- $a Čurová, Katarina $u Institute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
- 700 1_
- $a Siegfried, Leonard $u Institute of Medical and Clinical Microbiology, P. J. Šafárik University, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 62, č. 6 (2017), s. 525-530
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28361459 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180608 $b ABA008
- 991 __
- $a 20180608120349 $b ABA008
- 999 __
- $a ok $b bmc $g 1308171 $s 1017775
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 62 $c 6 $d 525-530 $e 20170330 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20180608
